NASHVILLE (August 18, 2026) – Holland & Knight represented DermCare Management LLC, a leader in specialized dermatology and cosmetic surgery practice management services, in the completion of a transaction combining operations with U.S. Dermatology Partners, a dermatology practice management group, to create one of the largest dermatology groups in the U.S. The transaction was announced on August 13.
The transaction unites two clinically focused organizations with aligned missions to expand access to high-quality dermatologic and aesthetic care, improve clinical outcomes and deliver a superior patient experience across rural, suburban, exurban and coastal communities throughout the U.S.
Headquartered in Hollywood, Florida, DermCare provides comprehensive operational support to dermatology practices across the U.S., partnering with more than 270 of the country's leading dermatology providers to deliver care to more than 1 million patients across Florida, Texas, Virginia, North Carolina and California.
Holland & Knight's representation of DermCare was led by Partners Morgan Ivey and David Marks (M&A). They were assisted by Associates Rebecca Greenwald and Fay Shaulson (M&A); Partners Stacy Hooper and Shane Morris (Tax); and Partner Daniel Patten (Healthcare Regulatory). Debt financing was led by Partners Rob Harris and Dustin Timblin (Financial Services).
More information on this transaction can be found here.
Recently recognized by Global M&A Network as Healthcare Law Firm of the Year and by Law360 as a Healthcare Practice Group of the Year, Holland & Knight is the largest healthcare law firm in the United States (Modern Healthcare). The Firm regularly ranks among the leading M&A and private equity law firms in reputable, benchmarking league tables published by Bloomberg, LSEG, Mergermarket, PitchBook and The Deal and was named M&A Law Firm of the Year by M&A Advisor in 2025. Firm lawyers provide sophisticated yet practical advice to healthcare acquirers, targets, sellers, investors and boards of directors and closed nearly 200 healthcare M&A and private equity transactions in 2025. Through the HK Deal Flow℠ program, Holland & Knight further facilitates deal leads for clients and prospective clients by matching acquisition or capital-raising opportunities with buyers and investors.